US Army testing universal vaccine to target all coronavirus variants

The US Army is wrapping up early clinical trials on a vaccine it hopes will target all existing coronavirus variants.Named SpFN, for Spike Ferritin Nanoparticle, it has shown promise in non-human primate trials and early human trial results are expected “this month,” according to a press release from the US Army Walter Reed Army Institute of Research released Thursday.The jab could also help protect against other coronaviruses beyond Covid-19, which could offer hope against future pandemics.The…

Read the original article at South China Morning Post